Maynard Um
-
-
-
-
-
-
-
UBS Starts Amneal Pharmaceuticals (AMRX) at Buy
-
-
-
-
-
-
-
Amneal receives FDA approval for two denosumab biosimilar drugs
-
-
-
-
-
-
-
Amneal reports Q2 2025 preliminary results with revenue growth
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) Tops Q1 EPS by 6c ; Offers Guidance
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) 4956 contracts of October 10 calls trade as share price up 5.2%
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags
-
417,415 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

